Wardynski & Partners and Deloitte Legal Advise on Bio-Rad Laboratories’ Acquisition of Curiosity Diagnostics

Wardynski & Partners and Deloitte Legal Advise on Bio-Rad Laboratories’ Acquisition of Curiosity Diagnostics

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Wardynski & Partners has advised Bio-Rad Laboratories on its acquisition of Curiosity Diagnostics from Scope Fluidics for a total consideration of up to USD 170 million in upfront and future milestone payments. Deloitte Legal advised Scope Fluidics on the sale.

According to Wardynski & Partners, “Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market. The PCR|ONE system offers an exceptionally easy procedure to perform a genetic test in disposable cartridges, in a fully automated procedure, in an exceptionally short time of 20 minutes.”

Bio-Rad develops, manufactures, and markets a range of products for the life science research and clinical diagnostic markets. Based in Hercules, California, Bio-Rad has a network of operations with approximately 7,900 employees worldwide and USD 2.9 billion in revenues in 2021.

Wardynski & Partners’ team included Partners Katarzyna Wojcik-Bakowska and Monika Gorska, Counsel Adam Pawlisz, Associate Krzysztof Drzymala, Attorney-at-law Katarzyna Jaroszynska and Junior Lawyer Oliwia Kruczynska.

Deloitte Legal’s team included Partner Ryszard Manteuffel, Associate Partner Robert Semczuk, Senior Managing Associate Jakub Labuz, and Associate Blazej Badera.